title: Allogeneic Hematopoietic Cell Transplantation Is Safe and Effective Treatment in Patients with Myelodysplastic Syndromes Seventy Years and Older.
authors.affiliation: Leukemia Program, Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio. Electronic address: mukhers2@ccf.org.
authors.forename: Sudipto
authors.initials: S
authors.lastname: Mukherjee
mesh_terms: D000368:Aged; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D009190:Myelodysplastic Syndromes / Q000628:therapy*; D019172:Transplantation Conditioning / Q000379:methods*; D014184:Transplantation, Homologous
keywords: Allogeneic; Center for International Blood and Marrow Transplant Research; European Society of Blood and Marrow Transplantation; Hematopoietic cell transplantation; Myelodysplastic syndromes; Older